Related Experiment Videos
Using NHSN's Antimicrobial Use Option to Monitor and Improve Antibiotic Stewardship in Neonates.
Erin N O'Leary1, Katharina L van Santen2, Erika M Edwards3,4,5
1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; ybi0@cdc.gov.
Hospital Pediatrics
|May 1, 2019
Summary
The Centers for Disease Control and Prevention
Area of Science:
- Healthcare epidemiology
- Infectious disease surveillance
- Antimicrobial stewardship
Background:
- The Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option provides valuable data for antibiotic stewardship programs.
- AU data allows for the measurement of antimicrobial consumption in hospitals before, during, and after interventions.
Purpose of the Study:
- To describe hospitals and neonatal patient care locations reporting to the NHSN AU Option in 2017.
- To examine the most frequently reported antimicrobial agents and analyze the variability of AU rates.
- To develop neonatal-specific Standardized Antimicrobial Administration Ratio (SAAR) agent categories and survey questions.
Main Methods:
- Utilized monthly AU data and annual facility survey data submitted to NHSN.
- Described reporting hospitals and neonatal patient care locations.
- Analyzed antimicrobial agent frequencies and AU rate variability.
Main Results:
- 351 US hospitals submitted AU data from neonatal units by April 2018.
- Ampicillin and gentamicin were the most common agents in 2017.
- AU rates were highest in level III NICUs, followed by other neonatal care levels.
Conclusions:
- A growing number of hospitals are submitting neonatal AU data to NHSN.
- NHSN aggregated AU data can serve as benchmarks for neonatal antimicrobial stewardship.
- Further development of the SAAR measure for neonatal AU is supported by this data.